Oral Azacitidine (CC-486) Plus Salvage Chemotherapy in Relapsed/Refractory Diffuse Large B Cell Lymphoma
Phase of Trial: Phase I
Latest Information Update: 14 Dec 2018
At a glance
- Drugs Azacitidine (Primary) ; Carboplatin; Etoposide; Ifosfamide; Rituximab
- Indications B-cell lymphoma; Diffuse large B cell lymphoma; Follicular lymphoma
- Focus Adverse reactions
- 04 Dec 2018 Status changed from not yet recruiting to recruiting.
- 31 Aug 2018 Biomarkers information updated
- 13 Jul 2018 Planned initiation date changed from 1 Jun 2018 to 1 Nov 2018.